Wolverine Trading, LLC Summit Therapeutics Inc. Transaction History
Wolverine Trading, LLC
- $83.2 Billion
- Q1 2025
A detailed history of Wolverine Trading, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 14,431 shares of SMMT stock, worth $380,834. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,431
Previous 32,837
56.05%
Holding current value
$380,834
Previous $586,000
52.56%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SMMT
# of Institutions
236Shares Held
86.8MCall Options Held
1.84MPut Options Held
3.13M-
Baker Bros. Advisors LP New York, NY24.4MShares$645 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$307 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$208 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$173 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$128 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.31B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...